missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ ATP13A2 Polyclonal Antibody, DyLight™ 650
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA522850
This item is not returnable.
View return policy
Description
Suggested positive control: human and mouse brain membrane prep lysate.
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. ATP13A2, otherwise known as PARK9, is a neuronal P-type ATPase gene underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia. ATP13A2 protein is located in the membrane of these lysosomes and is formed most strongly in the brain, especially in the substantia nigra, a brain region which is known to play a central role in Parkinson's disease.
Specifications
| ATP13A2 | |
| Polyclonal | |
| DyLight 650 | |
| ATP13A2 | |
| 1110012E06Rik; AA589443; AT132 antibody; Atp13a2; ATPase 13A2; ATPase type 13A2; Cation-transporting ATPase 13A2; CLN12; HSA9947; HSA9947 antibody; KRPPD; PARK9; probable cation-transporting ATPase 13A2; putative ATPase; RGD1307977; RP1-37C10.4 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 23400, 74772 | |
| 4°C, store in dark | |
| Liquid |
| Immunohistochemistry, Western Blot | |
| 0.75 mg/mL | |
| 50mM sodium borate with 0.05% sodium azide | |
| Q9CTG6, Q9NQ11 | |
| ATP13A2 | |
| A synthetic peptide made to an internal region of the human ATP13A2 protein (within residues 200-300). | |
| 100 μL | |
| Primary | |
| Human, Mouse | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction